Lee et al. [38] reported that hBMSC-derived exosomes could inhibit angiogenesis and tumor progression in vitro and in vivo by transferring miR-16 into tumor cells, which could target VEGF and reduce its expression in breast cancer cells. This evidence concerns the gene VEGFA and breast cancer.